KEY CONCEPTS: 1. Early recurrence of hepatitis C is universal. 2. Typical histopathologic features of hepatitis C virus (HCV) and acute allograft rejection (AAR) exist. 3. Early recurrent HCV may be differentiated from AAR. 4. Liver biopsy plays a role in diagnosing HCV and AAR. 5. Risk factors for recurrent HCV should be known. 6. The natural history of recurrent HCV should be known. 7. The future role of ancillary studies beyond liver biopsy is assessed.
No takes yet. Share an insight, caveat, or question.
Lydia M. Petrovic (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: